Physician profile
Naheed Shahid
NPI 1477508471
$1,321.11
in general payments reported to CMS, 2019-2025
19 companies · $269 in 2025
The $269 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $68.82 · 2022: $121 · 2023: $499 · 2024: $364 · 2025: $269.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,132.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,131.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $196.93 | 2022-2024 | Evenity, Otezla, Repatha |
| Novo Nordisk INC | $126.77 | 2023-2024 | Wegovy |
| Galderma Laboratories, L.P. | $125.48 | 2025 | |
| Lilly USA, LLC | $112.92 | 2022-2024 | Mounjaro, Zepbound |
| Abbvie INC. | $99.99 | 2021-2023 | Dalvance |
| Abbott Laboratories | $98.38 | 2023-2024 | Freestyle Libre 3 |
| Providence Medical Technology, INC. | $92.06 | 2025 | |
| Glaxosmithkline, LLC. | $80.65 | 2023-2024 | Shingrix |
| Astellas Pharma US INC | $77.38 | 2023-2024 | Veozah |
| Pfizer INC. | $67.48 | 2023-2024 | |
| Biohaven Pharmaceutical Holding Company LTD. | $45.87 | 2022 | |
| Lucid Diagnostics INC. | $35.71 | 2025 | |
| Otsuka America Pharmaceutical, INC. | $34.99 | 2023-2024 | Nuedexta |
| Exact Sciences Corporation | $30.32 | 2023-2024 | Cologuard Collection Kit |
| Biogen, INC. | $24.18 | 2024 | Skyclarys |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi Pasteur INC. | $21.30 | 2023 | |
| Dexcom, INC. | $20.32 | 2023 | Dexcom G6 Transmitter |
| Vertex Pharmaceuticals Incorporated | $15.70 | 2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.68 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Naheed Shahid listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.